105 web-programmer-developer-"https:"-"https:"-"https:"-"https:"-"https:" positions at Imperial College London in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
highly competitive salary, excellent pension scheme and career development opportunities. To provide hospitality catering services, ensure all catering deliveries are cleared within the given time frame as
-
complex trial involving the deliberate administration of S. aureus to healthy volunteers - work that is essential for understanding immune interaction and advancing vaccine development. We are looking for a
-
You will engage in cutting-edge translational research that develops computational models for assessing cardiac biomechanics and for predicting outcomes in cardiac diseases. This includes (1) a
-
that are key to growth and progression of ovarian carcinoma and that may be therapeutic targets. The postholder will carry out research programmes investigating the role of specific mutations of driving innate
-
. Ability to quickly develop strong and effective working relationships with a diverse range of stakeholders, both internally and externally. The opportunity to continue your career at a world-leading
-
accumulation of antibiotic drugs, rendering many ineffective. Despite a renewed focus on AMR research, there is still limited understanding of how to develop antibiotics that can cross these membranes and
-
, communication, and organisational skills. The ability to work flexibly, plan and prioritise a diverse workload, support colleagues, and work independently is crucial. The opportunity to continue your career at a
-
highly capable individual to develop new methods and characterisation tools to advance materials for photocatalysis and photoelectrochemistry. This includes their synthesis, characterisation, integration
-
This is an exciting opportunity to join the new GSK–Oxford–Imperial Modelling-Informed Medicine Centre (MiMeC) and develop imaging and airflow modelling research for early Chronic Obstructive
-
immunotherapy compared to placebo, in reducing the risk of developing asthma in a cohort of infants aged 5-12 months. 434 participants will be recruited across 12 sites in the UK. The trial is currently in the